Resources
Did you mean
biomedical (175 results)
- sort by:
- Relevance
- Date
- Popularity
- 3M acquired Acolyte Biomedica.(Company Announcements)
- 3M acquired Acolyte Biomedica, a provider of ... 3M acquired Acolyte Biomedica, a provider of automated microbial detection platforms, in February.
- Research articles 2007-04-15
- 3M Expands its Medical Diagnostics Platform with Acquisition of Acolyte Biomedica Ltd
- ST. PAUL, Minn. -- 3M announced today it has acquired Acolyte Biomedica Ltd., a Salisbury, U.K.-based provider of an automated microbial detection platform that aids in the rapid detection, diagnosis, and treatment of infectious diseases.
- Research articles 2007-02-14
- OXFORD BIOMEDICA PLC ANNOUNCES WYETH PRECLINICAL DATA
- FOR IMMEDIATE RELEASE 19 OCTOBER 2005 OXFORD BIOMEDICA ANNOUNCES...
- Research articles 2005-10-19
- EntreMed Inc. announces agreement with Oxford BioMedica PLC
- Rockville-based EntreMed Inc. a biopharmaceutical company that develops drugs to fight types of cancer, atherosclerosis and blindness, announced the execution of an agreement granting Oxford BioMedica PLC, of Oxford, U.K., exclusive worldwide rights to develop the localized delivery of two gene targets from EntreMed as a possible treatment for the...
- Research articles 2003-09-10
- Boston Biomedica Shares Jump on News of FDA Approval of Products.(Originated from The Boston Globe)
- Sep. 13--Shares in Boston Biomedica Inc. of West Bridgewater soared yesterday after the company announced five more products have won U.S. Food and Drug Administration approval. Sep. 13--Shares in Boston Biomedica Inc. of West Bridgewater soared yesterday after the company announced...
- Research articles 1997-09-13
- Oxford Biomedica To Present At SG Cowen Heath Care Conference
- FOR IMMEDIATE RELEASE 10 MARCH 2005 ...
- Research articles 2005-03-10
- Oxford Biomedica lands Sanofi-Aventis deal.
- Oxford Biomedica has signed a licensing agreement with Sanofi-Aventis for kidney-cancer drug TroVax. The French drug giant will pay an upfront fee of ?29m (GBP20m) and up to ?518m in milestone payments, as well as royalty fees if the product is succ Oxford Biomedica has...
- Research articles 2007-03-30
- The Boston Globe Emerging Businesses Column. (Originated from The Boston Globe)
- WEST BRIDGEWATER, Mass.--Dec. 14--Making sure that an AIDS-related test is accurate or that a manufacturer's batch of viral hepatitis test kits works from lot to lot has helped privately-held Boston Biomedica Inc. remain profitable and growing by 50 peWEST BRIDGEWATER, Mass.--Dec. 14--Making sure that an AIDS-related ...
- Research articles 1994-12-13
- J&J, Md. Technology Development Corp. unveil grants
- The first fruits of a partnership between the Maryland Technology Development Corp. and the Johnson & Johnson Corporate Office of Science and Technology have come in the form of three grants of $75,000 each to Maryland-based, early-stage health care companies. Biomedica Management Corp., Comprehensive Cancer Cells Diagnostics and WellDoc Communications...
- Research articles 2007-04-11
- U.S. BioDefense Files for Stem Cell Research Center of Excellence with National Institutes of Health with Research Collaborators from Los Alamos, CHOC, UCLA, and UCI and Liver Regeneration Technology from UCL Biomedica University College London
- CITY OF INDUSTRY, Calif. -- U.S. BioDefense, Inc. (OTCBB:UBDE) CEO David Chin is pleased to announce today that the company has filed a proposal in response to an RFA: `Center of Excellence in Translational Human Stem Cell Research' with the National Institutes of Health. NIH components participating organizations include the...
- Research articles 2005-03-30
- Hot Small Caps: REH Up on Profit Growth, Expansion Plans
- LONDON (Reuters UK) - Following is a round-up of key small cap movers on the London Stock Exchange on Wednesday. ---------------------------------------------------------------- ------------ Shares in Renewable Energy Holdings REH rise 4.3 percent to 48.5 pence after the renewable technologies operator moves into profit...
- News items 2008-09-03
- US human clone prompts urgent call for rapid regulation framework.
- The creation of the first cloned human embryo in the USA, revealed on 26 November, is prompting the European medical technology industry Eucomed to call again for a rapid regulatory response from the European Commission. (See Biomedical Materials, The creation of the first cloned human...
- Research articles 2002-01-01
- Comparison of the Biomedica NT-proBNP enzyme immunoassay and the Roche NT-proBNP chemiluminescence immunoassay: Implications for the prediction of symptomatic and asymptomatic structural heart disease
- The amino-terminal fragment of the B-type natriuretic peptide prohormone (NT-proBNP) is a marker for functional cardiac impairment and is increased in heart disease with or without symptoms of heart failure HF (1). There are indications that currently uThe amino-terminal fragment of the B-type natriuretic peptide prohormone (NT-proBNP) is a marker...
- Research articles 2003-06-01
- << Previous
- page 1 of 1
- Next >>
Content Types
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
- FedEx Kinko's is now FedEx Office
-
FedEx Office is the leading provider of business services and document solutions. FedEx Office also offers FedEx Express and FedEx Ground shipping to give you even greater access to FedEx. As a My FedEx Rewards member, you'll earn rewards on all of your eligible FedEx Office purchases.
- >>>Earn FedEx Rewards
- Dell: Built to fit your business needs.
-
Powerful, Dell is built to fit your business needs Customized systems, experts trained in small business, 24/7/365 support, and powerful, reliable technology. Dell, big results for small business.
- Learn More >>
- The ultra-portable, ultra-stylish Satellite® U405 is the right partner for small business.
-
Innovative USB Sleep'n Charge. Stylish Fusion™ finish. Ultra-portable. It's clear why the Satellite® U405 is a smart choice for you and your small business. Only from the laptop expert, Toshiba.
- explore.toshiba.com >>
